This page features the latest news about the Altamira Therapeutics stock. CYTO stock plunges to 52-week low, touches $0.4 In a turbulent market, CYTO, the stock for Auris Medical (TASE:PMCN ...
This page features the latest news about the Altamira Therapeutics stock. CYTO stock plunges to 52-week low, touches $0.4 In a turbulent market, CYTO, the stock for Auris Medical (TASE:PMCN ...
YTD Price Performance:-91.38% Average Trading Volume: 124,674 Technical Sentiment Consensus Rating: Buy Current Market Cap: $1.13M See more data about CYTO stock on TipRanks’ Stock Analysis page.
Researchers invited to gain early access to next-generation platform to optimize functional single-cell analysis workflows across expanded applications in life science R&D Cyto-Mine Chroma ...